Risk of herpes zoster among patients with chronic obstructive pulmonary disease: A population-based study

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 5, 2011, Pages

  Yang, Ya Wen ^a,b   Chen, Yi Hua ^c   Wang, Kuo Hsien ^a,b   Wang, Chen Yi ^d   Lin, Hui Wen ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HERPES ZOSTER; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SEX DIFFERENCE; TAIWAN;

EID: 79952819518     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.101137     Document Type: Article

References (30)

1. Straus SE, Oxman MN, Schmader KE. Varicella and herpes zoster. In: Wolff K, Goldsmith LA, Katz SI, et al. editors. Fitzpatrick's dermatology in general medicine. New York (NY): McGraw-Hill Companies, Inc; 2008. p. 1885-98.
2. Lydick E, Epstein RS, Himmelberger D, et al. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 1995;45:S52-3.
3. Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010;8:37.
4. Smitten AL, Choi HK, Hochberg MC, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007;57:1431-8. (Pubitemid 350308841)
5. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.
6. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-54.
7. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000;117:286S-91S.
8. Vestbo J, Hogg JC. Convergence of the epidemiology and pathology of COPD. Thorax 2006;61:86-8. (Pubitemid 43106984)
9. Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford) 2006;45:1370-5. (Pubitemid 44605471)
10. Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006;4:1483-90. (Pubitemid 44880029)
11. Hambleton S, Gershon AA. Preventing varicella-zoster disease. Clin Microbiol Rev 2005;18:70-80. (Pubitemid 40170661)
12. About NHI. Taipei (Taiwan): Bureau of National Health Insurance; 2010. Available: www.nhi.gov.tw/english/webdata.asp?menu=11&menu-id= 290&webdata-id=2974 (accessed 2010 Feb. 4).
13. Chen YC, Yeh, HY, et al. Taiwan's National Health Insurance Database: administrative health care database as study object in biblometrics. Scientometrics 2011;86:365-80.
14. Chung KH, Lee HC, Kao S, et al. Urbanicity and methods of suicide: a nationwide population-based study. J Urban Health 2008;85:136-45.
15. Souza RC, Pinheiro RS, Coeli CM, et al. The Charlson comorbidity index (CCI) for adjustment of hip fracture mortality in the elderly: analysis of the importance of recording secondary diagnoses. Cad Saude Publica 2008;24:315-22.
16. Patel ARC, Karmali S, Donaldson G. Prevalence of herpes zoster in COPD and relationships with inhaled corticosteroids, exacerbation frequency and FEV1. Am J Respir Crit Care Med 2010;181:A5926.
17. Prieto A, Reyes E, Bernstein ED, et al. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon). Am J Respir Crit Care Med 2001;163:1578-83. (Pubitemid 32578759)
18. Takabatake N, Sata M, Abe S, et al. Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratory tract infections in patients with COPD. Respir Med 2005;99:485-92. (Pubitemid 40347833)
19. Sharma G, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:573-80.
20. Cupps TR, Fauci AS. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982;65:133-55. (Pubitemid 12068797)
21. Holt PG, Thomas JA. Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology 1997;91:145-50. (Pubitemid 27196012)
22. Mukwaya G. Immunosuppressive effects and infections associated with corticosteroid therapy. Pediatr Infect Dis J 1988;7:499-504.
23. Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:2407-16.
24. Shu CC, Wu HD, Yu MC, et al. Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 2010;89:53-61.
25. Levy J, Zalkinder I, Kuperman O, et al. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol 1995;95:806-12.
26. Abzug MJ, Cotton MF. Severe chickenpox after intranasal use of corticosteroids. J Pediatr 1993;123:577-9. (Pubitemid 23287528)
27. Choong K, Zwaigenbaum L, Onyett H. Severe varicella after low dose inhaled corticosteroids. Pediatr Infect Dis J 1995;14:809-11.
28. Kalman CM, Laskin OL. Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med 1986;81:775-8.
29. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27:397-412. (Pubitemid 43180921)
30. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.